The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity ...
The Centers for Medicare and Medicaid Services (CMS) is rolling out a program this summer that will provide more affordable ...
The Trump administration decided to put the pilot on hold until at least 2027.
The BALANCE program was intended to cover weight-loss drugs for Medicaid beneficiaries, but is delayed. A new solution with ...
Big news for seniors: A new Medicare program will cover popular GLP-1 weight-loss drugs like Wegovy starting July 2026. Learn ...
The One Big Beautiful Bill Act (OBBB), signed into law by President Trump in July 2025, has brought about significant changes in the eligibility criteria for federal benefit programs. This legislation ...
As CMS sets its agenda under new leadership, there are critical opportunities to develop integrated care models for dual-eligible beneficiaries in non-integrated Medicare Advantage plans and ...